Skip to main content
TipRanks
Go Ultimate75% OFF

ScandiDos AB (SDOS) AI Stock Analysis

0 Followers
SE:SDOS

ScandiDos AB

(Nasdaq OMX AB:SDOS)

Select Model
Rating:40Underperform
Price Target:SEK 0.40â–¼(-5.00% Downside)
Action:reiterated
Date:11/07/26

ScandiDos AB receives a low score of 40, driven primarily by severe operational struggles, negative cash flows, and a staunch technical downtrend. While the company is buoyed by a highly stable, nearly debt-free balance sheet that mitigates immediate solvency risks, its lack of profitability, negative P/E ratio, and contracting top-line revenues present substantial barriers to long-term stock performance.

Positive Factors
Low financial leverageVery low debt relative to equity gives ScandiDos a conservative financial structure and reduces near-term solvency pressure. This supports flexibility to fund operations or targeted development while limiting the burden of interest and refinancing obligations.
Negative Factors
Declining revenueRevenue contraction signals weaker scale and limits the company’s ability to absorb fixed operating costs across its radiotherapy QA business. Unless growth resumes, declining sales can delay the path to profitability and constrain investment in products, commercial reach, and customer support.

ScandiDos AB (SDOS) vs. iShares MSCI Sweden ETF (EWD)

-60%-40%-20%0%20%40%SE:SDOS-60.00%EWD+16.08%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 29.93M
Dividend Yield
―
Average Volume (3M)
78.94K
Price to Earnings (P/E)
-3.4
Beta (1Y)
0.35
Revenue Growth
-19.44%
EPS Growth
-475.48%
Country
Sweden
Employees
25
Sector
General
Sector Strength
55
Industry
Medical - Devices

ScandiDos AB Business Overview & Revenue Model

Company Description

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internat...

ScandiDos AB Financial Statement Overview

Summary

Despite a resilient balance sheet with near-zero debt and strong equity, ScandiDos faces severe operational challenges, including shrinking revenues, persistent net losses, and ongoing free cash flow deficits.

Income Statement

15Very Negative

Balance Sheet

75Positive

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMApr 2025Apr 2024Apr 2023Apr 2023Apr 2021
Income Statement
Total Revenue49.97M54.22M60.43M61.55M60.43M59.99M
Gross Profit28.15M-2.71M47.55M52.95M47.55M49.73M
EBITDA-5.05M-439.00K-11.77M-3.00M-11.11M2.85M
Net Income-8.21M-3.44M-14.65M-9.12M-14.65M-1.40M
Balance Sheet
Total Assets72.08M65.97M73.38M72.42M81.47M77.16M
Cash, Cash Equivalents and Short-Term Investments16.00M4.36M10.06M3.55M1.53M9.00M
Total Debt2.32M000083.00K
Total Liabilities24.92M24.31M28.40M30.77M37.19M31.98M
Stockholders Equity47.16M41.66M44.98M41.65M44.29M45.18M
Cash Flow
Free Cash Flow-4.50M-6.79M-2.71M-16.31M-1.46M4.08M
Operating Cash Flow-2.79M-2.92M230.00K-11.90M1.49M8.64M
Investing Cash Flow-3.84M-3.87M-2.94M-4.37M-2.94M-4.63M
Financing Cash Flow11.66M0012.33M0-1.66M

ScandiDos AB Technical Analysis

Technical Analysis SentimentNegative
Last Price0.42

Price Trends

50DMA0.61Negative
100DMA0.73Negative
200DMA0.85Negative

Market Momentum

MACD-0.05Positive
RSI16.53Positive
STOCH14.94Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SDOS, the sentiment is Negative. The current price of 0.42 is below the 20-day moving average (MA) of 0.52, below the 50-day MA of 0.61, and below the 200-day MA of 0.85, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 16.53 is Positive, neither overbought nor oversold. The STOCH value of 14.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SDOS.

ScandiDos AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

SE:SDOS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:SECT.BSE:SECT.B78OutperformSEK 64.19B100.6130.26%0.70%13.94%5.70%
SE:PAXSE:PAX57NeutralSEK 1.55B-304.31-1.22%―34.05%-144.96%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
SE:OSSDSE:OSSD52NeutralSEK 354.00M-7.08――-11.89%-11.85%
SE:SDOSSE:SDOS40UnderperformSEK 29.93M-3.43――-19.44%-475.48%
SE:SCIBSE:SCIB40UnderperformSEK 128.49M-0.68-415.20%―54.94%47.64%
SE:SPECSE:SPEC40UnderperformSEK 19.12M-0.31-25.90%――78.15%

* General Sector Average

Performance Comparison

0%100%SE:SDOSSE:PAXSE:SCIBSE:SPECSE:SECT.BSE:OSSDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:SDOS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:SDOSScandiDos AB0.42-0.63-60.00%
SE:PAXPaxman AB66.406.4010.67%
SE:SCIBSciBase Holding AB9.10-9.99-52.34%
SE:SPECSpectraCure AB0.01-0.11-90.08%
SE:SECT.BSectra AB Class B329.0053.6019.46%
SE:OSSDOssDsign AB3.20-7.48-70.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026